Search

By Industry Solutions (1)
By Phase (1)
By Therapeutic Area (2)
Keywords (10)

Filters

Showing results 353 - 368 of 399 for .

Showing results 353 - 368 of 399 for .

Xcellerate® Monitoring - Small Molecule Development
Proactively identify, prevent and manage risks with a unique risk-based monitoring program that uncovers greater value in your studies.
Pharmacy Services | Healthcare Commercialization | Covance
Get your product to those who need it sooner. We offer a variety of ways to shorten the time between prescriber determination and prescription fulfillment.
Analytical Methods for Bioanalysis
Robust resources at the ready.
Xcellerate® Monitoring - Clinical Phase I-III
Proactively identify, prevent and manage risks with a unique risk-based monitoring program that uncovers greater value in your studies.
Xcellerate® Monitoring SaaS - Neuroscience
Whether insourcing or using multiple CROs, you can proactively mitigate trial risks in near real time with this innovative technology.
Xcellerate® Monitoring - Neuroscience
Proactively identify, prevent and manage risks with a unique risk-based monitoring program that uncovers greater value in your studies.
Sitemap | Covance
View Covance's sitemap to find content on our site.
Approach
Nimble Biopharma HomePartnerApproachValueTransitionContact Choose Subcategory Home Partner Approach Value Transition Contact Choose Subcategory Build vision into your development approach Shave up to 30% off your timelines Watch Peter Sausen, PhD explain how a programmatic approach to early development can shave up to 30% off your timelines to maximize your asset value at point of sale. When you’re ready to license or sell your asset, will you be optimally positioned? Today,...
journey-map-iframe
First Name * Last Name * Email Address * By entering your email address above, you agree to receive marketing communications from Covance Inc. You may withdraw your consent at any time. Company * Country * Please select United States United Kingdom Canada India Netherlands Australia South Africa France Germany Singapore Sweden Brazil -------------- Afghanistan Åland Islands Albania...
Partner
Nimble Biopharma HomePartnerApproachValueTransitionContact Choose Subcategory Home Partner Approach Value Transition Contact Choose Subcategory Get started with your venture Do you want the attention of potential partners, and the prowess to accelerate these discussions? More than half of today’s drugs are co-developed, so it’s likely you won’t develop yours alone. The challenge is finding the right partner ‒ early. Fortunately, new programs are available to enhance your...
The Bio Experience
Nimble Biopharma HomePartnerApproachValueTransitionContact Choose Subcategory Home Partner Approach Value Transition Contact Choose Subcategory The Bio Experience: Insights to grow the value of your asset LET'S GET STARTED Your experience. Your way. The drug development journey can be complex and stressful, but it doesn’t have to be. In fact, you can save time and money ‒ while maintaining study quality and data integrity ‒ and gain valuable insights about your asset. The...
Transition
Nimble Biopharma HomePartnerApproachValueTransitionContact Choose Subcategory Home Partner Approach Value Transition Contact Choose Subcategory Efficiently transition to clinical trials Today, more than ever before, agile biopharma firms are progressing fearlessly into late clinical phases. Why? Co-development partners are demanding clinical data that proves out the viability of your molecule, Breakthrough and Fast Track designations are enabling streamlined development tracks...
Value
Nimble Biopharma HomePartnerApproachValueTransitionContact Choose Subcategory Home Partner Approach Value Transition Contact Choose Subcategory Add value to your asset – start with the end in mind Discover the simple tools that ensure you “begin with the end in mind.” Listen as Bill Hanlon, PhD reveals the high-impact practices that so many others overlook. Effective planning makes all the difference in early drug development. By clearly defining your asset’s ultimate...
Frequently Asked Questions
Frequently Asked Questions Do I need to order Reflex Testing? Why did I get a QNS Report? What temperature should I store my kits? What are blank or Bar Reqs? How can I get my laboratory reports? What do I do when I receive a panic alert? Are new reports sent following a data revision? Can I change my kit order once it is placed? How to update your site’s contact information How do I order more kits and or supplies? How to request a data revision What is a Sample...
Accreditations and Certifications
Accreditations and Certifications Have perpetual peace-of-mind with our global and local certifications. We maintain a number of national laboratory certifications based on location. As a value-added service to our clients, we provide access to the current laboratory certification documents for each of our global central laboratory sites. Regulatory Accreditation Programs are continual processes: a laboratory remains accredited until otherwise notified. While a certificate provides...
Bioanalysis Education Center
Bioanalysis Education Center Covance leads the way in bioanalytical capabilities and solutions, igniting innovation with exceptional science and timely answers List of Non-proprietary/Generic Assays Non-Proprietary Assays for Bioanalysis (GLP) Publications AstraZeneca and Covance Laboratories Clinical Bioanalysis Alliance: an evolutionary outsourcing model Recommendations for the Development and Validation of Confirmatory Anti-drug Antibody Assays The evolution of the...